Digital Desk, London. Britain’s medicine regulator on Friday approved Pfizer/BioNtech’s Corona vaccine for use on children aged 12 to 15 years. The regulator said that now it will be up to the country’s Vaccination Committee (JCVI) to decide when it will roll out the vaccination to this age group. Children aged 12-15 are already being vaccinated in the US, while France and Germany are planning to vaccinate this age group from this month.
Britain’s Department of Health and Social Care said the JCVI would provide an update after making its decision. June Raine, chief executive of the UK Medicines and Healthcare products Regulatory Agency, said in a statement that her agency had carefully reviewed clinical trial data in children aged 12 to 15 years. We have concluded that the COVID-19 vaccine from Pfizer/BioNtech is safe and effective in this age group. The benefits of the vaccine outweigh any risks.
Earlier on May 28, the European Medicines Agency (EMA) announced the approval of Pfizer’s vaccine for children aged 12 to 15 years. The European Union’s drug regulatory body had said that this vaccine has not seen any serious side effects on children. This vaccine has been thoroughly reviewed. After this we have come to the conclusion that this vaccine will not have serious side effects on children. EMA’s head of vaccine strategy, Marco Cavaleri, said the trial did not show serious side effects on children. So there is no need to worry.
Pfizer and BioNTech conducted clinical trials in March on children aged 12 to 15 years. The European Medical Association and Britain’s drug regulatory body have reviewed data from this trial.